Angiotensen II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1

Hypertension Research

Volumn 31, Issue 5, 2008, Pages 987-998

  Abe, Keiko ^a   Nakashima, Hidekatsu ^a   Ishida, Mari ^a   Miho, Narimasa ^a   Sawano, Mariko ^a   Soe, Nwe Nwe ^a   Kurabayashi, Masahiko ^b   Chayama, Kazuaki ^a   Yoshizumi, Masao ^a   Ishida, Takafumi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Osteopontin; Signal transduction; Vascular remodeling; Vascular smooth muscle cells

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOTENSIN II; GUANINE NUCLEOTIDE BINDING PROTEIN; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; PROTEIN INHIBITOR; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; RAS PROTEIN; TRANSCRIPTION FACTOR ETS 1; CYCLOPEPTIDE; ETS1 PROTEIN, RAT; FOCAL ADHESION KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; YM 254890; YM-254890;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GENE MUTATION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; BALLOON DILATATION; CAROTID ARTERY; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; INTIMA; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; BALLOON DILATATION; CAROTID ARTERIES; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; PEPTIDES, CYCLIC; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEIN C-ETS-1; RAS PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUNICA INTIMA;

EID: 46049096117     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.987     Document Type: Article

References (47)

1. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS: Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-1061.
2. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998; 152: 353-358.
3. deBlois D, Lombardi DM, Su EJ, Clowes AW, Schwartz SM, Giachelli CM: Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. Hypertension 1996; 28: 1055-1063.
4. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-1696.
5. Panda D, Kundu GC, Lee BI, et al: Potential roles of osteopontin and alpha Vbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 1997; 94: 9308-9313.
6. Shimizu H, Takahashi M, Takeda S, et al: Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 2004; 77: 1661-1667.
7. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994; 74: 214-224.
8. Isoda K, Nishikawa K, Kamezawa Y, et al: Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002; 91: 77-82.
9. Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F: Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003; 107: 679-681.
10. Bruemmer D, Collins AR, Noh G, et al: Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003; 112: 1318-1331.
11. Matsui Y, Rittling SR, Okamoto H, et al: Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23: 1029-1034.
12. Singh K, Sirokman G, Communal C, et al: Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 1999; 33: 663-670.
13. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F: Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001; 60: 1645-1657.
14. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82-C97.
15. Ishida T, Ishida M, Suero J, Takahashi M, Berk BC: Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 1999; 103: 789-797.
16. Miho N, Ishida T, Kuwaba N, et al: Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells. Cardiovasc Res 2005; 68: 289-298.
17. Ishida M, Ishida T, Thomas SM, Berk BC: Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 1998; 82: 7-12.
18. Taylor SJ, Shalloway D: Cell cycle-dependent activation of Ras. Curr Biol 1996; 6: 1621-1627.
19. Usui M, Egashira K, Ohtani K, et al: Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys. FASEB J 2002; 16: 1839-1840.
20. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK: p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998; 273: 15022-15029.
21. Ohtsu H, Suzuki H, Nakashima H, et al: Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells. Hypertension 2006; 48: 534-540.
22. Ishida M, Ishida T, Nakashima H, et al: Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells. Circ Res 2003; 93: 1218-1224.
23. Denhardt DT, Guo X: Osteopontin: a protein with diverse functions. FASEB J 1993; 7: 1475-1482.
24. Campos AH, Zhao Y, Pollman MJ, Gibbons GH: DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease. Circ Res 2003; 92: 111-1118.
25. Ueno H, Yamamoto H, Ito S, Li JJ, Takeshita A: Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler Thromb Vasc Biol 1997; 17: 898-904.
26. Work LM, McPhaden AR, Pyne NJ, Pyne S, Wadsworth RM, Wainwright CL: Short-term local delivery of an inhibitor of Ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty. Circulation 2001; 104: 1538-1543.
27. George J, Afek A, Keren P, et al: Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice. Circulation 2002; 105: 2416-2422.
28. 2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996; 271: 14169-14175.
29. Avraham S, London R, Fu Y, et al: Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem 1995; 270: 27742-27751.
30. Murasawa S, Mori Y, Nozawa Y, et al: Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in angiotensin II induced Ras/ERK signaling. Hypertension 1998; 32: 668-675.
31. Eguchi S, Numaguchi K, Iwasaki H, et al: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 1998; 273: 8890-8896.
32. Mifune M, Ohtsu H, Suzuki H, et al: G protein coupling and second messenger generation are indispensable for metallo-protease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem 2005; 280: 26592-26599.
33. Sadoshima J, Izumo S: The heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996; 15: 775-787.
34. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC: Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 1995; 77: 1053-1059.
35. Roelle S, Grosse R, Buech T, Chubanov V, Gudermann T: Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 2008; 27: 1737-1748.
36. Blaukat A, Ivankovic-Dikic I, Gronroos E, et al: Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J Biol Chem 1999; 274: 14893-14901.
37. Wei L, Yang Y, Zhang X, Yu Q: Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 2004; 23: 9052-9061.
38. Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K: Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Etsl and Flil. Nucleic Acids Res 2005; 33: 3540-3549.
39. Hultgardh-Nilsson A, Cercek B, Wang JW, et al: Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res 1996; 78: 589-595.
40. Wai PY, Mi Z, Gao C, Guo H, Marroquin C, Kuo PC: Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 2006; 281: 18973-18982.
41. Zhan Y, Brown C, Maynard E, et al: Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005; 115: 2508-2516.
42. Renault MA, Jalvy S, Belloc I, et al: AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ Res 2003; 93: 674-681.
43. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105: 1605-1612.
44. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-456.
45. Mukherjee BB, Nemir M, Beninati S, et al: Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann N Y Acad Sci 1995; 760: 201-212.
46. Martin SM, Schwartz JL, Giachelli CM, Ratner BD: Enhancing the biological activity of immobilized osteopontin using a type-1 collagen affinity coating. J Biomed Mater Res A 2004; 70: 10-19.
47. Zhan Y, Kim S, Izumi Y, et al: Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 2003; 23: 795-801.